342 related articles for article (PubMed ID: 31888501)
1. Composite genome sequence of Bacillus clausii, a probiotic commercially available as Enterogermina
Khatri I; Sharma G; Subramanian S
BMC Microbiol; 2019 Dec; 19(1):307. PubMed ID: 31888501
[TBL] [Abstract][Full Text] [Related]
2. Quantitative and qualitative characterization of commercially available oral suspension of probiotic products containing Bacillus Clausii spores.
Kharwar A; Bazaz MR; Dandekar MP
BMC Microbiol; 2022 Sep; 22(1):217. PubMed ID: 36114449
[TBL] [Abstract][Full Text] [Related]
3. Microbiological and molecular characterization of commercially available probiotics containing Bacillus clausii from India and Pakistan.
Patrone V; Molinari P; Morelli L
Int J Food Microbiol; 2016 Nov; 237():92-97. PubMed ID: 27543819
[TBL] [Abstract][Full Text] [Related]
4. Complete Genomes of Bacillus coagulans S-lac and Bacillus subtilis TO-A JPC, Two Phylogenetically Distinct Probiotics.
Khatri I; Sharma S; Ramya TN; Subramanian S
PLoS One; 2016; 11(6):e0156745. PubMed ID: 27258038
[TBL] [Abstract][Full Text] [Related]
5. Tolerance to challenges miming gastrointestinal transit by spores and vegetative cells of Bacillus clausii.
Cenci G; Trotta F; Caldini G
J Appl Microbiol; 2006 Dec; 101(6):1208-15. PubMed ID: 17105550
[TBL] [Abstract][Full Text] [Related]
6. Kinetics of Intestinal Presence of Spores Following Oral Administration of Bacillus clausii Formulations: Three Single-Centre, Crossover, Randomised, Open-Label Studies.
Navarra P; Milleri S; Perez Iii M; Uboldi MC; Pellegrino P; Bois De Fer B; Morelli L
Eur J Drug Metab Pharmacokinet; 2021 May; 46(3):375-384. PubMed ID: 33683700
[TBL] [Abstract][Full Text] [Related]
7. Survival and persistence of Bacillus clausii in the human gastrointestinal tract following oral administration as spore-based probiotic formulation.
Ghelardi E; Celandroni F; Salvetti S; Gueye SA; Lupetti A; Senesi S
J Appl Microbiol; 2015 Aug; 119(2):552-9. PubMed ID: 25973914
[TBL] [Abstract][Full Text] [Related]
8. Bacillus clausii for Gastrointestinal Disorders: A Narrative Literature Review.
Acosta-Rodríguez-Bueno CP; Abreu Y Abreu AT; Guarner F; Guno MJV; Pehlivanoğlu E; Perez M
Adv Ther; 2022 Nov; 39(11):4854-4874. PubMed ID: 36018495
[TBL] [Abstract][Full Text] [Related]
9. Secreted Compounds of the Probiotic Bacillus clausii Strain O/C Inhibit the Cytotoxic Effects Induced by Clostridium difficile and Bacillus cereus Toxins.
Ripert G; Racedo SM; Elie AM; Jacquot C; Bressollier P; Urdaci MC
Antimicrob Agents Chemother; 2016 Jun; 60(6):3445-54. PubMed ID: 27001810
[TBL] [Abstract][Full Text] [Related]
10. Complete genome sequence of bacteriocin-producing Lactobacillus plantarum KLDS1.0391, a probiotic strain with gastrointestinal tract resistance and adhesion to the intestinal epithelial cells.
Jia FF; Zhang LJ; Pang XH; Gu XX; Abdelazez A; Liang Y; Sun SR; Meng XC
Genomics; 2017 Oct; 109(5-6):432-437. PubMed ID: 28676278
[TBL] [Abstract][Full Text] [Related]
11. Bio-removal of tetracycline antibiotics under the consortium with probiotics Bacillus clausii T and Bacillus amyloliquefaciens producing biosurfactants.
Liu CX; Xu QM; Yu SC; Cheng JS; Yuan YJ
Sci Total Environ; 2020 Mar; 710():136329. PubMed ID: 31918182
[TBL] [Abstract][Full Text] [Related]
12. Characterization of a new erm-related macrolide resistance gene present in probiotic strains of Bacillus clausii.
Bozdogan B; Galopin S; Leclercq R
Appl Environ Microbiol; 2004 Jan; 70(1):280-4. PubMed ID: 14711653
[TBL] [Abstract][Full Text] [Related]
13. Molecular characterization and identification of Bacillus clausii Strains marketed for use in oral bacteriotherapy.
Senesi S; Celandroni F; Tavanti A; Ghelardi E
Appl Environ Microbiol; 2001 Feb; 67(2):834-9. PubMed ID: 11157251
[TBL] [Abstract][Full Text] [Related]
14. A chromosomal chloramphenicol acetyltransferase determinant from a probiotic strain of Bacillus clausii.
Galopin S; Cattoir V; Leclercq R
FEMS Microbiol Lett; 2009 Jun; 296(2):185-9. PubMed ID: 19459958
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic Prospective of a Spore-Forming Probiotic-Bacillus clausii UBBC07 Against Acetaminophen-Induced Uremia in Rats.
Patel C; Patel P; Acharya S
Probiotics Antimicrob Proteins; 2020 Mar; 12(1):253-258. PubMed ID: 30879230
[TBL] [Abstract][Full Text] [Related]
16. Protective action of Bacillus clausii probiotic strains in an in vitro model of Rotavirus infection.
Paparo L; Tripodi L; Bruno C; Pisapia L; Damiano C; Pastore L; Berni Canani R
Sci Rep; 2020 Jul; 10(1):12636. PubMed ID: 32724066
[TBL] [Abstract][Full Text] [Related]
17. Current Progress and Future Perspectives on the Use of Bacillus clausii.
Ghelardi E; Abreu Y Abreu AT; Marzet CB; Álvarez Calatayud G; Perez M; Moschione Castro AP
Microorganisms; 2022 Jun; 10(6):. PubMed ID: 35744764
[TBL] [Abstract][Full Text] [Related]
18. Functional annotation of the genome unravels probiotic potential of Bacillus coagulans HS243.
Kapse NG; Engineer AS; Gowdaman V; Wagh S; Dhakephalkar PK
Genomics; 2019 Jul; 111(4):921-929. PubMed ID: 29859262
[TBL] [Abstract][Full Text] [Related]
19. Content Analysis of Commercially Available Probiotics.
Yadav P; Sharma P; Arora R
Indian Pediatr; 2018 Apr; 55(4):344-345. PubMed ID: 29428923
[TBL] [Abstract][Full Text] [Related]
20. Bacillus clausii probiotic strains: antimicrobial and immunomodulatory activities.
Urdaci MC; Bressollier P; Pinchuk I
J Clin Gastroenterol; 2004 Jul; 38(6 Suppl):S86-90. PubMed ID: 15220667
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
